Loading organizations...

§ Private Profile · Los Altos Hills, CA, USA
Drug platform preserving mitochondrial health in degenerative diseases.
Retrotope has raised $20.0M across 1 funding round.
Retrotope has raised $20.0M in total across 1 funding round.
Retrotope has raised $20.0M across 1 funding round. Most recently, it raised $20.0M Series C in July 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 19, 2019 | $20M Series C | Timur Artemev, Nitin Mehta | Morningside | Announced |
Retrotope has raised $20.0M in total across 1 funding round.
Retrotope's investors include Timur Artemev, Nitin Mehta, Morningside.